SCHEMBL2550996

SCHEMBL2550996

CC(C)C(Cl)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7373341 0.96
SCHEMBL31524001 0.79 ALDH1A1 (0.33)
SCHEMBL30084770 0.75 ALDH1A1 (0.31)
SCHEMBL31524041 0.75 ALDH1A1 (0.31)
SCHEMBL30575221 0.75 ALDH1A1 (0.31)
Zinc Ion SCHEMBL30387204 0.75 ALDH1A1 (0.31)
SCHEMBL30161695 0.75 ALDH1A1 (0.31)
Hydrochloric Acid SCHEMBL27394136 0.74
SCHEMBL10532011 0.72
SCHEMBL479164 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724103-A Isopromazine specific impurity and analysis method and removal method thereof 广安凯特制药有限公司 2021-04-30 CN disclosed
EP-3031799-B1 AROMATIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2018-04-04 EP disclosed
US-9776962-B2 Aromatic compounds with GPR40 agonistic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-10-03 US disclosed
US-9650664-B2 Use of photocleavable compounds FEMTONICS KFT (HU) 2017-05-16 US disclosed
WO-2017035401-A1 AMIDE COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 WO disclosed
WO-2017035408-A1 COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 WO disclosed
EP-3031799-A1 AROMATIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2016-06-15 EP disclosed
US-20160115128-A1 AROMATIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-04-28 US disclosed
EP-2791130-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS BOEHRINGER INGELHEIM INT (DE) 2016-03-16 EP disclosed
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
EP-1250324-A1 BIARYL COMPOUNDS, THEIR PREPARATION AND THEIR USE IN THERAPY RiboTargets Limited (GB) 2002-10-23 EP disclosed
WO-2001055111-A1 BIARYL COMPOUNDS, THEIR PREPARATION AND THEIR USE IN THERAPY RIBOTARGETS LIMITED (GB) 2001-08-02 WO disclosed
EP-1028982-A1 COMPOSITIONS PROVIDING IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS AND PROCESSES FOR IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS FMC CORPORATION (US) 2000-08-23 EP disclosed
WO-1999025740-A1 COMPOSITIONS PROVIDING IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS AND PROCESSES FOR IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS FMC CORPORATION (US) 1999-05-27 WO disclosed
EP-0338087-A1 FUSED PYRAZOLE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR MEDICINAL USE Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1989-10-25 EP disclosed
US-4618599-A WATER SOLUBILITY RHONE-POULENC SANTE (FR) 1986-10-21 US disclosed
US-4617377-A BACTERICIDES RHONE-POULENC SANTE (FR) 1986-10-14 US disclosed
US-4529813-A Preparation of 2-halogeno-3-alkylvinylcyclobutan-1-one BAYER AKTIENGESELLSCHAFT (DE) 1985-07-16 US disclosed
US-4395413-A NICOTINE ANTIALLERGEN, ANESTHETIC, ANALGESIC, HYPOTENSIVE, AND ANTIULCER AGENT EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1983-07-26 US disclosed
US-4077999-A ANALGESIC, SPASMOLYTIC EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1978-03-07 US disclosed